Amarantus Bioscience Holdings Inc (AMBS)

[PENNYS ToMILLIONS]

Amarantus BioSciences Co-Founders honored among 2012’s
“50 Most Important African-Americans in Technology”
SUNNYVALE, CA – September 25, 2012 – Amarantus Biosciences, Inc. (OTCBB: AMBS), a California-based biotechnology company developing new treatments and diagnostics for Parkinson’s disease (PD) and Traumatic Brain Injury (TBI) centered around its patented therapeutic protein MANF, today announced that Co-Founders Dr. John and Gerald Commissiong were selected among BlackMoney.com‘s 13th annual “50 Most Important African-Americans in Technology” for 2012. The selectees will gather in Washington, D.C. January 15th, 2013 for the Innovation & Equity Symposium: Keeping America First in Technology: Public Innovation and Supplier Diversity ( http://www.blackmoney.com/35117 ).
Dr.